Overview

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

Status:
Completed

Trial end date:
2000-11-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Vaccines made from a person's tumor may help the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have undergone surgery to remove stage I, stage II, or stage IIIA non-small cell lung cancer or stage I or stage II mesothelioma.

Phase:

Phase 1

Details

Lead Sponsor:

Roswell Park Cancer Institute

Treatments:

Cyclophosphamide